vs
Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and MARINEMAX INC (HZO). Click either name above to swap in a different company.
Astrana Health, Inc. is the larger business by last-quarter revenue ($950.5M vs $527.4M, roughly 1.8× MARINEMAX INC). On growth, Astrana Health, Inc. posted the faster year-over-year revenue change (42.9% vs -16.5%). Over the past eight quarters, Astrana Health, Inc.'s revenue compounded faster (53.3% CAGR vs -16.6%).
Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.
MarineMax Inc. is a leading recreational boat and yacht retailer primarily operating in the United States. It offers new and pre-owned leisure vessels, alongside related services including maintenance, repair, financing, insurance coverage, yacht chartering, and boating lifestyle events, catering to private boating enthusiasts across North America.
ASTH vs HZO — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $950.5M | $527.4M |
| Net Profit | $6.6M | — |
| Gross Margin | — | 34.4% |
| Operating Margin | 1.9% | 2.1% |
| Net Margin | 0.7% | — |
| Revenue YoY | 42.9% | -16.5% |
| Net Profit YoY | 184.4% | — |
| EPS (diluted) | $0.12 | $0.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $527.4M | ||
| Q4 25 | $950.5M | $505.2M | ||
| Q3 25 | $956.0M | $552.2M | ||
| Q2 25 | $654.8M | $657.2M | ||
| Q1 25 | $620.4M | $631.5M | ||
| Q4 24 | $665.2M | $468.5M | ||
| Q3 24 | $478.7M | $563.1M | ||
| Q2 24 | $486.3M | $757.7M |
| Q1 26 | — | — | ||
| Q4 25 | $6.6M | $-7.9M | ||
| Q3 25 | $373.0K | $-851.0K | ||
| Q2 25 | $9.4M | $-52.1M | ||
| Q1 25 | $6.7M | $3.3M | ||
| Q4 24 | $-7.8M | $18.1M | ||
| Q3 24 | $16.1M | $4.0M | ||
| Q2 24 | $19.2M | $31.6M |
| Q1 26 | — | 34.4% | ||
| Q4 25 | — | 31.8% | ||
| Q3 25 | — | 34.7% | ||
| Q2 25 | — | 30.4% | ||
| Q1 25 | — | 30.0% | ||
| Q4 24 | — | 36.2% | ||
| Q3 24 | — | 34.3% | ||
| Q2 24 | — | 32.0% |
| Q1 26 | — | 2.1% | ||
| Q4 25 | 1.9% | 1.0% | ||
| Q3 25 | 2.0% | 2.5% | ||
| Q2 25 | 3.1% | -6.3% | ||
| Q1 25 | 3.3% | 3.6% | ||
| Q4 24 | 0.1% | 8.3% | ||
| Q3 24 | 5.9% | 4.8% | ||
| Q2 24 | 6.2% | 8.1% |
| Q1 26 | — | — | ||
| Q4 25 | 0.7% | -1.6% | ||
| Q3 25 | 0.0% | -0.2% | ||
| Q2 25 | 1.4% | -7.9% | ||
| Q1 25 | 1.1% | 0.5% | ||
| Q4 24 | -1.2% | 3.9% | ||
| Q3 24 | 3.4% | 0.7% | ||
| Q2 24 | 3.9% | 4.2% |
| Q1 26 | — | $0.14 | ||
| Q4 25 | $0.12 | $-0.36 | ||
| Q3 25 | $0.01 | $0.08 | ||
| Q2 25 | $0.19 | $-2.42 | ||
| Q1 25 | $0.14 | $0.14 | ||
| Q4 24 | $-0.14 | $0.77 | ||
| Q3 24 | $0.33 | $0.17 | ||
| Q2 24 | $0.40 | $1.37 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $429.5M | $189.1M |
| Total DebtLower is stronger | — | $338.7M |
| Stockholders' EquityBook value | $779.3M | — |
| Total Assets | $2.2B | $2.4B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $189.1M | ||
| Q4 25 | $429.5M | $164.6M | ||
| Q3 25 | $463.4M | $170.4M | ||
| Q2 25 | $342.1M | $151.0M | ||
| Q1 25 | $260.9M | $203.5M | ||
| Q4 24 | $290.8M | $145.0M | ||
| Q3 24 | $350.3M | $224.3M | ||
| Q2 24 | $327.7M | $242.4M |
| Q1 26 | — | $338.7M | ||
| Q4 25 | — | — | ||
| Q3 25 | — | $393.2M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $391.2M | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | $779.3M | $932.8M | ||
| Q3 25 | $775.5M | $937.2M | ||
| Q2 25 | $765.5M | $940.5M | ||
| Q1 25 | $745.4M | $993.4M | ||
| Q4 24 | $712.7M | $993.5M | ||
| Q3 24 | $704.6M | $975.8M | ||
| Q2 24 | $678.9M | $967.6M |
| Q1 26 | — | $2.4B | ||
| Q4 25 | $2.2B | $2.4B | ||
| Q3 25 | $2.2B | $2.5B | ||
| Q2 25 | $1.4B | $2.5B | ||
| Q1 25 | $1.3B | $2.7B | ||
| Q4 24 | $1.4B | $2.6B | ||
| Q3 24 | $1.3B | $2.6B | ||
| Q2 24 | $1.3B | $2.6B |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 0.42× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.40× | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.9M | — |
| Free Cash FlowOCF − Capex | $-6.0M | — |
| FCF MarginFCF / Revenue | -0.6% | — |
| Capex IntensityCapex / Revenue | 0.3% | — |
| Cash ConversionOCF / Net Profit | -0.44× | — |
| TTM Free Cash FlowTrailing 4 quarters | $104.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-2.9M | $16.9M | ||
| Q3 25 | $10.0M | $61.5M | ||
| Q2 25 | $90.9M | $84.9M | ||
| Q1 25 | $16.6M | $72.5M | ||
| Q4 24 | $-10.9M | $-146.1M | ||
| Q3 24 | $34.0M | $-782.0K | ||
| Q2 24 | $23.2M | $86.3M |
| Q1 26 | — | — | ||
| Q4 25 | $-6.0M | $8.3M | ||
| Q3 25 | $7.4M | $48.0M | ||
| Q2 25 | $89.5M | $68.5M | ||
| Q1 25 | $13.6M | $59.8M | ||
| Q4 24 | $-13.5M | $-164.4M | ||
| Q3 24 | $31.7M | $-17.5M | ||
| Q2 24 | $20.4M | $71.1M |
| Q1 26 | — | — | ||
| Q4 25 | -0.6% | 1.7% | ||
| Q3 25 | 0.8% | 8.7% | ||
| Q2 25 | 13.7% | 10.4% | ||
| Q1 25 | 2.2% | 9.5% | ||
| Q4 24 | -2.0% | -35.1% | ||
| Q3 24 | 6.6% | -3.1% | ||
| Q2 24 | 4.2% | 9.4% |
| Q1 26 | — | — | ||
| Q4 25 | 0.3% | 1.7% | ||
| Q3 25 | 0.3% | 2.4% | ||
| Q2 25 | 0.2% | 2.5% | ||
| Q1 25 | 0.5% | 2.0% | ||
| Q4 24 | 0.4% | 3.9% | ||
| Q3 24 | 0.5% | 3.0% | ||
| Q2 24 | 0.6% | 2.0% |
| Q1 26 | — | — | ||
| Q4 25 | -0.44× | — | ||
| Q3 25 | 26.69× | — | ||
| Q2 25 | 9.65× | — | ||
| Q1 25 | 2.48× | 21.97× | ||
| Q4 24 | — | -8.09× | ||
| Q3 24 | 2.11× | -0.20× | ||
| Q2 24 | 1.21× | 2.74× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
HZO
| Retail Operations | $525.3M | 100% |
| Product Manufacturing | $23.7M | 4% |
